EU indices up | TA focus on L'Oreal


European stocks report | AstraZeneca | Infineon Technologies | Volkswagen | EQT...

Stocks (2)

Friday, European stocks were broadly lower. The Stoxx Europe 600 slipped 0.20%, Germany's DAX dropped 0.70%, France's CAC 40 fell 0.46%, while the U.K.'s FTSE 100 was little changed.

62% of STOXX 600 constituents traded lower or unchanged Friday.
64% of the shares trade above their 20D MA vs 66% Thursday (above the 20D moving average).
59% of the shares trade above their 200D MA vs 59% Thursday (above the 20D moving average).

The Euro Stoxx 50 Volatility index eased 0.76pt to 25.62, a new 52w high.

3mths relative high: Industrial
3mths relative low: Food & Beverage

The 10yr Bund yield was unchanged to -0.64% (below its 20D MA). The 2yr-10yr yield spread fell 1bp to -16bps (above its 20D MA).

GE 08:00: Sep Current Account, exp.: E16.5B
GE 08:00: Sep Imports MoM s.a, exp.: 5.8%
GE 08:00: Sep Exports MoM s.a, exp.: 2.4%
GE 08:00: Sep Balance of Trade s.a, exp.: E15.7B
GE 08:00: Sep Balance of Trade, exp.: E12.8B
FR 15:00: 3-Mth BTF auction, exp.: -0.68%
FR 15:00: 12-Mth BTF auction, exp.: -0.65%
FR 15:00: 6-Mth BTF auction, exp.: -0.65%

In Asian trading hours, EUR/USD extend its rally to 1.1890 and GBP/USD rose to 1.3180. USD/JPY edged up to 103.40.

Spot gold climbed to $1,956 an ounce.

AstraZeneca, a pharmaceutical giant, said its Calquence has been approved in the E.U. for the treatment of chronic lymphocytic leukaemia.

Aviva, an international insurance firm, formed a bullish gap on a daily chart last Friday (November 6).

Anglo American, a mining company, was upgraded to "overweight" from "equalweight" at Morgan Stanley.

Infineon Technologies, a semiconductor manufacturer, reported a 4Q net income of 109 million euros, compared with a net loss of 128 million euros in the prior quarter, and revenue rose 15% on quarter to 2.49 billion euros. The company sees 1Q 2021 revenue of 2.4 - 2.7 billion euros and full-year 2021 revenue of around 10.5 billion euros (plus or minus 5%).

Volkswagen's, an automobile group, Traton announced that it has agreed to acquire the remaining shares of Navistar not already owned for 44.50 dollars per share in cash, representing approximately 3.7 billion dollars.

Danone, a French food-processing firm, marked an INSIDE BAR last Friday (November 6) suggesting short-term bullishness ahead.

BioMerieux, a specialist in the diagnosis of infectious diseases, closed ABOVE its 21-Day Moving Average last Friday (November 6) for the first time since October 19.  

L'Oreal, a personal care company, was upgraded to "equalweight" from "underweight" at Morgan Stanley.

From a technical point of view, prices have recently escaped from a symmetrical triangle in place since June 2020. Furthermore, the stock has pulled back on the pattern's upper boundary, while the 6-month moving average has supported the stock's rebound. Above 275E, targets are set at 330E and 350E in extension.

Source: TradingView, GAIN Capital

EQT, an investment group, is planning an IPO for its 5 billion euros German software company SUSE, reported Bloomberg citing people familiar with the matter.

More from Equities

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.